Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
Jean
J
Klastersky
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D000077336:Caspofungin; D054714:Echinocandins; D005334:Fever / Q000209:etiology; D006801:Humans; D055666:Lipopeptides; D008081:Liposomes; D009181:Mycoses / Q000188:drug therapy* / Q000517:prevention & control; D009369:Neoplasms / Q000150:complications / Q000628:therapy; D009503:Neutropenia / Q000209:etiology; D010455:Peptides / Q000627:therapeutic use*; D010456:Peptides, Cyclic; D011743:Pyrimidines / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D008081:Liposomes; D010455:Peptides; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D000666:Amphotericin B; D000077336:Caspofungin; D065819:Voriconazole